Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Korean Circulation Journal ; : 266-272, 2015.
Artigo em Inglês | WPRIM | ID: wpr-28562

RESUMO

Patients with diabetes have an increased risk for development of cardiomyopathy, even in the absence of well known risk factors like coronary artery disease and hypertension. Diabetic cardiomyopathy was first recognized approximately four decades ago. To date, several pathophysiological mechanisms thought to be responsible for this new entity have also been recognized. In the presence of hyperglycemia, non-enzymatic glycosylation of several proteins, reactive oxygen species formation, and fibrosis lead to impairment of cardiac contractile functions. Impaired calcium handling, increased fatty acid oxidation, and increased neurohormonal activation also contribute to this process. Demonstration of left ventricular hypertrophy, early diastolic and late systolic dysfunction by sensitive techniques, help us to diagnose diabetic cardiomyopathy. Traditional treatment of heart failure is beneficial in diabetic cardiomyopathy, but specific strategies for prevention or treatment of cardiac dysfunction in diabetic patients has not been clarified yet. In this review we will discuss clinical and experimental studies focused on pathophysiology of diabetic cardiomyopathy, and summarize diagnostic and therapeutic approaches developed towards this entity.


Assuntos
Humanos , Cálcio , Cardiomiopatias , Doença da Artéria Coronariana , Diabetes Mellitus , Cardiomiopatias Diabéticas , Fibrose , Glicosilação , Insuficiência Cardíaca , Hiperglicemia , Hipertensão , Hipertrofia Ventricular Esquerda , Espécies Reativas de Oxigênio , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA